The NMIBC curriculum will provide easily accessible and engaging educational material to enable urologists to explore the developments and management strategies for NMIBC, ranging from handling BCG-unresponsive cases to understanding the quality of life implications of radical treatments.
UROwebinar: NMIBC – BCG Unresponsive management in 2025 and new developments
This recording will focus on Bacillus Calmette-Guérin–unresponsive (BCG-U) non-muscle-invasive bladder cancer (NMIBC). You can also enroll in the e-course “NMIBC – BCG Unresponsive management in 2025 and new developments” to gain 1 CME point.
This educational activity has been funded by Ferring. The educational programme of this online activity has been a collaboration with Ferring, but independently developed and approved by the European Association of Urology.